anmelden
Sarepta Therapeutics Aktie
15,84
EUR
+0,16
EUR
+1,02
%
18,39
USD
+0,15
USD
+0,82
%
Sarepta Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Sarepta Therapeutics Aktie Analyse
| 21.08.19 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 01.10.18 | Sarepta Therapeutics Overweight | Cantor Fitzgerald | |
| 21.06.18 | Sarepta Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
| 20.06.18 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 19.06.18 | Sarepta Therapeutics Buy | H.C. Wainwright & Co. | |
| 11.05.18 | Sarepta Therapeutics overweight | Barclays Capital | |
| 07.05.18 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 07.05.18 | Sarepta Therapeutics Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
| 13.03.18 | Sarepta Therapeutics Buy | H.C. Wainwright & Co. | |
| 22.01.18 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 01.12.17 | Sarepta Therapeutics Buy | H.C. Wainwright & Co. | |
| 20.07.17 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 28.04.17 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 05.04.17 | Sarepta Therapeutics buy | SunTrust | |
| 02.03.17 | Sarepta Therapeutics Buy | Instinet | |
| 01.03.17 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 22.02.17 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 16.12.16 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 28.10.16 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 10.10.16 | Sarepta Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 28.09.16 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 20.09.16 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 19.09.16 | Sarepta Therapeutics Outperform | RBC Capital Markets | |
| 19.09.16 | Sarepta Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
| 07.06.16 | Sarepta Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 01.06.16 | Sarepta Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 26.04.16 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 26.04.16 | Sarepta Therapeutics Reduce | SunTrust Robinson Humphrey, Inc. | |
| 26.04.16 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 22.04.16 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 01.03.16 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 02.10.15 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 26.08.15 | Sarepta Therapeutics Buy | ROTH Capital Partners, LLC | |
| 22.05.15 | Sarepta Therapeutics Strong Buy | WBB Securities | |
| 20.05.15 | Sarepta Therapeutics Buy | Canaccord Adams | |
| 20.05.15 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 20.05.15 | Sarepta Therapeutics Buy | ROTH Capital Partners, LLC | |
| 06.05.15 | Sarepta Therapeutics Outperform | Robert W. Baird & Co. Incorporated | |
| 02.03.15 | Sarepta Therapeutics Buy | Needham & Company, LLC | |
| 23.01.15 | Sarepta Therapeutics Sector Perform | RBC Capital Markets | |
| 26.11.14 | Sarepta Therapeutics Strong Buy | WBB Securities | |
| 28.10.14 | Sarepta Therapeutics Neutral | Robert W. Baird & Co. Incorporated | |
Werbung
Werbung
